nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—FGFR3—skull—meningioma	0.0296	0.0909	CbGeAlD
Pazopanib—FGFR2—skull—meningioma	0.0194	0.0595	CbGeAlD
Pazopanib—TAOK1—medulla oblongata—meningioma	0.00592	0.0182	CbGeAlD
Pazopanib—MAP3K9—cerebellum—meningioma	0.00557	0.0171	CbGeAlD
Pazopanib—SH2B3—medulla oblongata—meningioma	0.00557	0.0171	CbGeAlD
Pazopanib—TAOK1—spinal cord—meningioma	0.00528	0.0162	CbGeAlD
Pazopanib—SH2B3—spinal cord—meningioma	0.00497	0.0153	CbGeAlD
Pazopanib—FGFR3—medulla oblongata—meningioma	0.00466	0.0143	CbGeAlD
Pazopanib—RIOK2—medulla oblongata—meningioma	0.00466	0.0143	CbGeAlD
Pazopanib—FGF1—brainstem—meningioma	0.00463	0.0143	CbGeAlD
Pazopanib—MAP3K9—brain—meningioma	0.00453	0.0139	CbGeAlD
Pazopanib—FGFR2—brainstem—meningioma	0.00438	0.0135	CbGeAlD
Pazopanib—STK36—medulla oblongata—meningioma	0.00419	0.0129	CbGeAlD
Pazopanib—TAOK1—cerebellum—meningioma	0.00418	0.0129	CbGeAlD
Pazopanib—FGFR3—spinal cord—meningioma	0.00416	0.0128	CbGeAlD
Pazopanib—RIOK2—spinal cord—meningioma	0.00416	0.0128	CbGeAlD
Pazopanib—PI4KB—medulla oblongata—meningioma	0.00412	0.0127	CbGeAlD
Pazopanib—SH2B3—cerebellum—meningioma	0.00394	0.0121	CbGeAlD
Pazopanib—TAOK3—brainstem—meningioma	0.00383	0.0118	CbGeAlD
Pazopanib—PI4KB—spinal cord—meningioma	0.00368	0.0113	CbGeAlD
Pazopanib—PIP4K2C—medulla oblongata—meningioma	0.00362	0.0111	CbGeAlD
Pazopanib—LIMK2—spinal cord—meningioma	0.00361	0.0111	CbGeAlD
Pazopanib—FGFR1—medulla oblongata—meningioma	0.00359	0.011	CbGeAlD
Pazopanib—MAP2K5—brainstem—meningioma	0.00343	0.0105	CbGeAlD
Pazopanib—TAOK1—brain—meningioma	0.0034	0.0105	CbGeAlD
Pazopanib—STK16—cerebellum—meningioma	0.00335	0.0103	CbGeAlD
Pazopanib—RIOK2—cerebellum—meningioma	0.0033	0.0101	CbGeAlD
Pazopanib—FGFR3—cerebellum—meningioma	0.0033	0.0101	CbGeAlD
Pazopanib—BMPR1B—cerebellum—meningioma	0.00326	0.01	CbGeAlD
Pazopanib—FGF1—medulla oblongata—meningioma	0.00323	0.00994	CbGeAlD
Pazopanib—PIP4K2C—spinal cord—meningioma	0.00323	0.00992	CbGeAlD
Pazopanib—FGFR1—spinal cord—meningioma	0.0032	0.00984	CbGeAlD
Pazopanib—SH2B3—brain—meningioma	0.0032	0.00984	CbGeAlD
Pazopanib—AURKC—brain—meningioma	0.00315	0.00969	CbGeAlD
Pazopanib—KIT—brainstem—meningioma	0.00304	0.00935	CbGeAlD
Pazopanib—STK36—cerebellum—meningioma	0.00296	0.00911	CbGeAlD
Pazopanib—PI4KB—cerebellum—meningioma	0.00292	0.00897	CbGeAlD
Pazopanib—FGF1—spinal cord—meningioma	0.00288	0.00886	CbGeAlD
Pazopanib—PLK4—brain—meningioma	0.00288	0.00886	CbGeAlD
Pazopanib—LIMK2—cerebellum—meningioma	0.00286	0.0088	CbGeAlD
Pazopanib—FLT1—medulla oblongata—meningioma	0.00283	0.0087	CbGeAlD
Pazopanib—EPHB6—medulla oblongata—meningioma	0.0028	0.0086	CbGeAlD
Pazopanib—FGFR2—spinal cord—meningioma	0.00272	0.00837	CbGeAlD
Pazopanib—STK16—brain—meningioma	0.00272	0.00837	CbGeAlD
Pazopanib—LYN—brain—meningioma	0.00269	0.00828	CbGeAlD
Pazopanib—RIOK2—brain—meningioma	0.00268	0.00824	CbGeAlD
Pazopanib—FGFR3—brain—meningioma	0.00268	0.00824	CbGeAlD
Pazopanib—TAOK3—medulla oblongata—meningioma	0.00267	0.0082	CbGeAlD
Pazopanib—MAP3K19—brain—meningioma	0.00265	0.00815	CbGeAlD
Pazopanib—BMPR1B—brain—meningioma	0.00265	0.00815	CbGeAlD
Pazopanib—PIP4K2C—cerebellum—meningioma	0.00256	0.00787	CbGeAlD
Pazopanib—FGFR1—cerebellum—meningioma	0.00254	0.00781	CbGeAlD
Pazopanib—FLT1—spinal cord—meningioma	0.00252	0.00776	CbGeAlD
Pazopanib—EPHB6—spinal cord—meningioma	0.00249	0.00767	CbGeAlD
Pazopanib—MAP3K2—cerebellum—meningioma	0.00243	0.00746	CbGeAlD
Pazopanib—STK36—brain—meningioma	0.00241	0.0074	CbGeAlD
Pazopanib—KDR—medulla oblongata—meningioma	0.00239	0.00735	CbGeAlD
Pazopanib—MAP2K5—medulla oblongata—meningioma	0.00239	0.00735	CbGeAlD
Pazopanib—TAOK3—spinal cord—meningioma	0.00238	0.00732	CbGeAlD
Pazopanib—PI4KB—brain—meningioma	0.00237	0.00728	CbGeAlD
Pazopanib—PDGFRA—spinal cord—meningioma	0.00236	0.00727	CbGeAlD
Pazopanib—CSF1R—medulla oblongata—meningioma	0.00233	0.00718	CbGeAlD
Pazopanib—LIMK2—brain—meningioma	0.00233	0.00715	CbGeAlD
Pazopanib—FGF1—cerebellum—meningioma	0.00229	0.00703	CbGeAlD
Pazopanib—FGFR2—cerebellum—meningioma	0.00216	0.00664	CbGeAlD
Pazopanib—KDR—spinal cord—meningioma	0.00213	0.00656	CbGeAlD
Pazopanib—MAP2K5—spinal cord—meningioma	0.00213	0.00656	CbGeAlD
Pazopanib—KIT—medulla oblongata—meningioma	0.00212	0.00652	CbGeAlD
Pazopanib—FLT4—brain—meningioma	0.00209	0.00643	CbGeAlD
Pazopanib—CSF1R—spinal cord—meningioma	0.00208	0.0064	CbGeAlD
Pazopanib—PIP4K2C—brain—meningioma	0.00208	0.00639	CbGeAlD
Pazopanib—PDGFRB—medulla oblongata—meningioma	0.00207	0.00637	CbGeAlD
Pazopanib—FGFR1—brain—meningioma	0.00206	0.00634	CbGeAlD
Pazopanib—FLT1—cerebellum—meningioma	0.002	0.00615	CbGeAlD
Pazopanib—EPHB6—cerebellum—meningioma	0.00198	0.00608	CbGeAlD
Pazopanib—MAP3K2—brain—meningioma	0.00197	0.00606	CbGeAlD
Pazopanib—STK10—cerebellum—meningioma	0.00189	0.00582	CbGeAlD
Pazopanib—KIT—spinal cord—meningioma	0.00189	0.00581	CbGeAlD
Pazopanib—TAOK3—cerebellum—meningioma	0.00189	0.0058	CbGeAlD
Pazopanib—PDGFRA—cerebellum—meningioma	0.00187	0.00576	CbGeAlD
Pazopanib—FGF1—brain—meningioma	0.00186	0.00571	CbGeAlD
Pazopanib—PDGFRB—spinal cord—meningioma	0.00185	0.00568	CbGeAlD
Pazopanib—FGFR2—brain—meningioma	0.00175	0.00539	CbGeAlD
Pazopanib—KDR—cerebellum—meningioma	0.00169	0.0052	CbGeAlD
Pazopanib—MAP2K5—cerebellum—meningioma	0.00169	0.0052	CbGeAlD
Pazopanib—CSF1R—cerebellum—meningioma	0.00165	0.00508	CbGeAlD
Pazopanib—FLT1—brain—meningioma	0.00162	0.005	CbGeAlD
Pazopanib—EPHB6—brain—meningioma	0.00161	0.00494	CbGeAlD
Pazopanib—STK10—brain—meningioma	0.00154	0.00473	CbGeAlD
Pazopanib—TAOK3—brain—meningioma	0.00153	0.00471	CbGeAlD
Pazopanib—PDGFRA—brain—meningioma	0.00152	0.00468	CbGeAlD
Pazopanib—KIT—cerebellum—meningioma	0.0015	0.00461	CbGeAlD
Pazopanib—PDGFRB—cerebellum—meningioma	0.00146	0.0045	CbGeAlD
Pazopanib—KDR—brain—meningioma	0.00137	0.00422	CbGeAlD
Pazopanib—MAP2K5—brain—meningioma	0.00137	0.00422	CbGeAlD
Pazopanib—CSF1R—brain—meningioma	0.00134	0.00412	CbGeAlD
Pazopanib—KIT—brain—meningioma	0.00122	0.00374	CbGeAlD
Pazopanib—PDGFRB—brain—meningioma	0.00119	0.00366	CbGeAlD
Pazopanib—ABCG2—medulla oblongata—meningioma	0.00116	0.00358	CbGeAlD
Pazopanib—CYP2D6—brainstem—meningioma	0.00114	0.00352	CbGeAlD
Pazopanib—ABCG2—spinal cord—meningioma	0.00104	0.00319	CbGeAlD
Pazopanib—ABCG2—cerebellum—meningioma	0.000823	0.00253	CbGeAlD
Pazopanib—CYP2C8—brain—meningioma	0.000687	0.00211	CbGeAlD
Pazopanib—ABCG2—brain—meningioma	0.000668	0.00205	CbGeAlD
Pazopanib—ABCB1—medulla oblongata—meningioma	0.000574	0.00176	CbGeAlD
Pazopanib—CYP2D6—cerebellum—meningioma	0.000564	0.00173	CbGeAlD
Pazopanib—ABCB1—spinal cord—meningioma	0.000512	0.00157	CbGeAlD
Pazopanib—CYP2D6—brain—meningioma	0.000458	0.00141	CbGeAlD
Pazopanib—ABCB1—cerebellum—meningioma	0.000406	0.00125	CbGeAlD
Pazopanib—ABCB1—brain—meningioma	0.000329	0.00101	CbGeAlD
Pazopanib—PDGFRA—Signaling Pathways—PGR—meningioma	0.00011	0.000162	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—ERBB2—meningioma	0.00011	0.000162	CbGpPWpGaD
Pazopanib—LCK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.000109	0.000162	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ALAD—meningioma	0.000108	0.000161	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—TP53—meningioma	0.000108	0.00016	CbGpPWpGaD
Pazopanib—FGFR1—Disease—HES1—meningioma	0.000107	0.000159	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—HES1—meningioma	0.000107	0.000159	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—PDGFB—meningioma	0.000107	0.000158	CbGpPWpGaD
Pazopanib—LYN—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000107	0.000158	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by NGF—AKT1—meningioma	0.000106	0.000157	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—HES1—meningioma	0.000105	0.000155	CbGpPWpGaD
Pazopanib—KIT—Immune System—PDGFB—meningioma	0.000105	0.000155	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—PTEN—meningioma	0.000105	0.000155	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.000105	0.000155	CbGpPWpGaD
Pazopanib—LCK—DAP12 interactions—AKT1—meningioma	0.000104	0.000155	CbGpPWpGaD
Pazopanib—LCK—Signaling by FGFR in disease—AKT1—meningioma	0.000104	0.000155	CbGpPWpGaD
Pazopanib—LCK—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.000104	0.000155	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—ERBB2—meningioma	0.000104	0.000154	CbGpPWpGaD
Pazopanib—KIT—Signaling by NGF—AKT1—meningioma	0.000104	0.000154	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR—AKT1—meningioma	0.000103	0.000153	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—SMO—meningioma	0.000103	0.000153	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—ERBB2—meningioma	0.000103	0.000152	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—PTEN—meningioma	0.000103	0.000152	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR in Cancer—AKT1—meningioma	0.000102	0.000152	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—HES1—meningioma	0.000102	0.000151	CbGpPWpGaD
Pazopanib—LCK—Signaling by PDGF—AKT1—meningioma	0.000102	0.000151	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—SMO—meningioma	0.000101	0.000149	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—ERBB2—meningioma	0.000101	0.000149	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—PTEN—meningioma	0.000101	0.000149	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—PTEN—meningioma	0.0001	0.000149	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—PDGFB—meningioma	0.0001	0.000148	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—PDGFB—meningioma	9.94e-05	0.000147	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—PDGFB—meningioma	9.91e-05	0.000147	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—PGR—meningioma	9.87e-05	0.000146	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—ERBB2—meningioma	9.87e-05	0.000146	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—PTEN—meningioma	9.86e-05	0.000146	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by NGF—AKT1—meningioma	9.85e-05	0.000146	CbGpPWpGaD
Pazopanib—FGFR2—Disease—PDGFB—meningioma	9.84e-05	0.000146	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by NGF—AKT1—meningioma	9.83e-05	0.000146	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—PTEN—meningioma	9.75e-05	0.000144	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—HES1—meningioma	9.74e-05	0.000144	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—PTEN—meningioma	9.72e-05	0.000144	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TSHB—meningioma	9.72e-05	0.000144	CbGpPWpGaD
Pazopanib—KIT—Disease—PDGFB—meningioma	9.67e-05	0.000143	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PGR—meningioma	9.66e-05	0.000143	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—ERBB2—meningioma	9.66e-05	0.000143	CbGpPWpGaD
Pazopanib—LCK—B Cell Activation—AKT1—meningioma	9.65e-05	0.000143	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—HES1—meningioma	9.64e-05	0.000143	CbGpPWpGaD
Pazopanib—FGFR3—Disease—ERBB2—meningioma	9.59e-05	0.000142	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ALAD—meningioma	9.45e-05	0.00014	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—PTEN—meningioma	9.36e-05	0.000139	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—PTEN—meningioma	9.34e-05	0.000138	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—AKT1—meningioma	9.29e-05	0.000138	CbGpPWpGaD
Pazopanib—LCK—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	9.24e-05	0.000137	CbGpPWpGaD
Pazopanib—FGFR1—Disease—PDGFB—meningioma	9.17e-05	0.000136	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—PDGFB—meningioma	9.15e-05	0.000136	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—AKT1—meningioma	9.14e-05	0.000135	CbGpPWpGaD
Pazopanib—ITK—Immune System—AKT1—meningioma	9.11e-05	0.000135	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—PDGFB—meningioma	8.96e-05	0.000133	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—PDGFB—meningioma	8.93e-05	0.000132	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	8.92e-05	0.000132	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ALAD—meningioma	8.9e-05	0.000132	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—PTEN—meningioma	8.86e-05	0.000131	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by NGF—AKT1—meningioma	8.85e-05	0.000131	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—ERBB2—meningioma	8.79e-05	0.00013	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—AKT1—meningioma	8.76e-05	0.00013	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—PTEN—meningioma	8.76e-05	0.00013	CbGpPWpGaD
Pazopanib—LYN—Immune System—PDGFB—meningioma	8.74e-05	0.00013	CbGpPWpGaD
Pazopanib—LCK—Platelet activation, signaling and aggregation—AKT1—meningioma	8.73e-05	0.000129	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—PDGFB—meningioma	8.73e-05	0.000129	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—AKT1—meningioma	8.65e-05	0.000128	CbGpPWpGaD
Pazopanib—FGF1—Immune System—ERBB2—meningioma	8.63e-05	0.000128	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—PTEN—meningioma	8.58e-05	0.000127	CbGpPWpGaD
Pazopanib—FGFR3—Adaptive Immune System—AKT1—meningioma	8.42e-05	0.000125	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—PTEN—meningioma	8.41e-05	0.000125	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—PDGFB—meningioma	8.33e-05	0.000123	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—SMO—meningioma	8.26e-05	0.000122	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—ERBB2—meningioma	8.24e-05	0.000122	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—PDGFB—meningioma	8.24e-05	0.000122	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—PTEN—meningioma	8.24e-05	0.000122	CbGpPWpGaD
Pazopanib—FGFR3—Disease—PTEN—meningioma	8.18e-05	0.000121	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—HES1—meningioma	8.06e-05	0.000119	CbGpPWpGaD
Pazopanib—FGF1—Disease—ERBB2—meningioma	7.97e-05	0.000118	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PGR—meningioma	7.92e-05	0.000117	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—ERBB2—meningioma	7.92e-05	0.000117	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—HES1—meningioma	7.91e-05	0.000117	CbGpPWpGaD
Pazopanib—LCK—Disease—HES1—meningioma	7.73e-05	0.000115	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ALAD—meningioma	7.54e-05	0.000112	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—HES1—meningioma	7.51e-05	0.000111	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—TP53—meningioma	7.5e-05	0.000111	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—PTEN—meningioma	7.5e-05	0.000111	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—HES1—meningioma	7.49e-05	0.000111	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—meningioma	7.44e-05	0.00011	CbGpPWpGaD
Pazopanib—FGF1—Immune System—PTEN—meningioma	7.36e-05	0.000109	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—AKT1—meningioma	7.28e-05	0.000108	CbGpPWpGaD
Pazopanib—LCK—Immune System—PDGFB—meningioma	7.16e-05	0.000106	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—ERBB2—meningioma	7.14e-05	0.000106	CbGpPWpGaD
Pazopanib—LCK—Signaling by NGF—AKT1—meningioma	7.1e-05	0.000105	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—PTEN—meningioma	7.03e-05	0.000104	CbGpPWpGaD
Pazopanib—KIT—Immune System—ERBB2—meningioma	7.02e-05	0.000104	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—AKT1—meningioma	6.99e-05	0.000104	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—TSHB—meningioma	6.99e-05	0.000104	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—PDGFB—meningioma	6.89e-05	0.000102	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—TP53—meningioma	6.86e-05	0.000102	CbGpPWpGaD
Pazopanib—FGF1—Disease—PTEN—meningioma	6.8e-05	0.000101	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—PDGFB—meningioma	6.77e-05	0.0001	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—PTEN—meningioma	6.75e-05	0.0001	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HES1—meningioma	6.75e-05	0.0001	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—ERBB2—meningioma	6.72e-05	9.95e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—ERBB2—meningioma	6.66e-05	9.87e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—ERBB2—meningioma	6.64e-05	9.84e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—PDGFB—meningioma	6.61e-05	9.8e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HES1—meningioma	6.61e-05	9.79e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—ERBB2—meningioma	6.6e-05	9.77e-05	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—TP53—meningioma	6.5e-05	9.64e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—ERBB2—meningioma	6.48e-05	9.6e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—PDGFB—meningioma	6.42e-05	9.52e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—PDGFB—meningioma	6.41e-05	9.49e-05	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—AKT1—meningioma	6.36e-05	9.43e-05	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—AKT1—meningioma	6.33e-05	9.38e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—ERBB2—meningioma	6.15e-05	9.11e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—ERBB2—meningioma	6.13e-05	9.09e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—PTEN—meningioma	6.09e-05	9.03e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—TSHB—meningioma	6.09e-05	9.02e-05	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	6.09e-05	9.02e-05	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—AKT1—meningioma	6.03e-05	8.93e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—ERBB2—meningioma	6e-05	8.9e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—ERBB2—meningioma	5.98e-05	8.87e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—PTEN—meningioma	5.98e-05	8.87e-05	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—AKT1—meningioma	5.92e-05	8.77e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—ERBB2—meningioma	5.86e-05	8.68e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—ERBB2—meningioma	5.85e-05	8.67e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALAD—meningioma	5.82e-05	8.62e-05	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—AKT1—meningioma	5.79e-05	8.58e-05	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—AKT1—meningioma	5.79e-05	8.58e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—PDGFB—meningioma	5.77e-05	8.55e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—TSHB—meningioma	5.74e-05	8.5e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—PTEN—meningioma	5.73e-05	8.49e-05	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—AKT1—meningioma	5.69e-05	8.42e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—PTEN—meningioma	5.68e-05	8.41e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—PTEN—meningioma	5.66e-05	8.39e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PDGFB—meningioma	5.65e-05	8.37e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—PTEN—meningioma	5.62e-05	8.34e-05	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—AKT1—meningioma	5.62e-05	8.33e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—AKT1—meningioma	5.6e-05	8.3e-05	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—AKT1—meningioma	5.6e-05	8.29e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—ERBB2—meningioma	5.58e-05	8.27e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—ERBB2—meningioma	5.52e-05	8.19e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—PTEN—meningioma	5.52e-05	8.19e-05	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—AKT1—meningioma	5.49e-05	8.14e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HES1—meningioma	5.42e-05	8.03e-05	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—AKT1—meningioma	5.4e-05	7.99e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—AKT1—meningioma	5.38e-05	7.97e-05	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—TP53—meningioma	5.33e-05	7.9e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—PTEN—meningioma	5.24e-05	7.77e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—PTEN—meningioma	5.23e-05	7.75e-05	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	5.14e-05	7.62e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—PTEN—meningioma	5.12e-05	7.59e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—TP53—meningioma	5.12e-05	7.58e-05	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—AKT1—meningioma	5.1e-05	7.56e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—PTEN—meningioma	5.1e-05	7.56e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—AKT1—meningioma	5.05e-05	7.48e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—PTEN—meningioma	5e-05	7.4e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—PTEN—meningioma	4.99e-05	7.39e-05	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—AKT1—meningioma	4.94e-05	7.32e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—TSHB—meningioma	4.86e-05	7.2e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—AKT1—meningioma	4.85e-05	7.18e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—ERBB2—meningioma	4.8e-05	7.12e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—PTEN—meningioma	4.76e-05	7.05e-05	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—AKT1—meningioma	4.75e-05	7.03e-05	CbGpPWpGaD
Pazopanib—FGFR3—Disease—AKT1—meningioma	4.71e-05	6.98e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—PTEN—meningioma	4.71e-05	6.98e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PDGFB—meningioma	4.63e-05	6.86e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—ERBB2—meningioma	4.62e-05	6.84e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—ERBB2—meningioma	4.54e-05	6.72e-05	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—AKT1—meningioma	4.5e-05	6.67e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—ERBB2—meningioma	4.43e-05	6.57e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—AKT1—meningioma	4.32e-05	6.4e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—ERBB2—meningioma	4.31e-05	6.38e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—ERBB2—meningioma	4.29e-05	6.36e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—meningioma	4.27e-05	6.33e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—AKT1—meningioma	4.24e-05	6.29e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—PTEN—meningioma	4.09e-05	6.07e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—AKT1—meningioma	4.05e-05	6e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—PTEN—meningioma	3.94e-05	5.84e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—AKT1—meningioma	3.92e-05	5.8e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TP53—meningioma	3.91e-05	5.79e-05	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—AKT1—meningioma	3.89e-05	5.77e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—ERBB2—meningioma	3.87e-05	5.73e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—PTEN—meningioma	3.87e-05	5.73e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—ERBB2—meningioma	3.79e-05	5.61e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—PTEN—meningioma	3.78e-05	5.6e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TSHB—meningioma	3.75e-05	5.56e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—PTEN—meningioma	3.67e-05	5.44e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—PTEN—meningioma	3.66e-05	5.43e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PTEN—meningioma	3.61e-05	5.36e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—AKT1—meningioma	3.51e-05	5.2e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TP53—meningioma	3.49e-05	5.18e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—AKT1—meningioma	3.45e-05	5.11e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TP53—meningioma	3.4e-05	5.05e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PTEN—meningioma	3.31e-05	4.91e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—AKT1—meningioma	3.3e-05	4.89e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—PTEN—meningioma	3.3e-05	4.89e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—AKT1—meningioma	3.27e-05	4.85e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—AKT1—meningioma	3.26e-05	4.84e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TP53—meningioma	3.25e-05	4.81e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—AKT1—meningioma	3.24e-05	4.8e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PTEN—meningioma	3.23e-05	4.79e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—AKT1—meningioma	3.18e-05	4.72e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—ERBB2—meningioma	3.1e-05	4.6e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTEN—meningioma	3.07e-05	4.55e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—AKT1—meningioma	3.02e-05	4.48e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—AKT1—meningioma	3.01e-05	4.47e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—meningioma	2.97e-05	4.4e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—AKT1—meningioma	2.95e-05	4.37e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—AKT1—meningioma	2.94e-05	4.36e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—AKT1—meningioma	2.88e-05	4.27e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—AKT1—meningioma	2.88e-05	4.26e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—AKT1—meningioma	2.74e-05	4.06e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—AKT1—meningioma	2.72e-05	4.02e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TP53—meningioma	2.69e-05	3.98e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PTEN—meningioma	2.65e-05	3.92e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TP53—meningioma	2.64e-05	3.91e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TP53—meningioma	2.51e-05	3.71e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TP53—meningioma	2.5e-05	3.7e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—AKT1—meningioma	2.36e-05	3.5e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—AKT1—meningioma	2.27e-05	3.36e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TP53—meningioma	2.25e-05	3.34e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—AKT1—meningioma	2.23e-05	3.3e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TP53—meningioma	2.2e-05	3.27e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—AKT1—meningioma	2.18e-05	3.23e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—AKT1—meningioma	2.12e-05	3.14e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—AKT1—meningioma	2.11e-05	3.13e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—AKT1—meningioma	2.08e-05	3.09e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—AKT1—meningioma	1.91e-05	2.83e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTEN—meningioma	1.9e-05	2.82e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—AKT1—meningioma	1.9e-05	2.82e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—AKT1—meningioma	1.86e-05	2.76e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TP53—meningioma	1.81e-05	2.68e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—AKT1—meningioma	1.77e-05	2.62e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTEN—meningioma	1.66e-05	2.46e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTEN—meningioma	1.56e-05	2.32e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—AKT1—meningioma	1.53e-05	2.26e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTEN—meningioma	1.32e-05	1.96e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—AKT1—meningioma	1.1e-05	1.63e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTEN—meningioma	1.02e-05	1.51e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—AKT1—meningioma	9.56e-06	1.42e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—AKT1—meningioma	9.01e-06	1.33e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—AKT1—meningioma	7.63e-06	1.13e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—AKT1—meningioma	5.89e-06	8.73e-06	CbGpPWpGaD
